This study was to investigate antimicrobial resistance and bacterial distribution of gram negative bacilli isolated from intensive care unit (ICU) in the First Bethune Hospital in 2009. Disk diffusion test was used to study the antimicrobial resistance. The data were analyzed by WHONET 5 software according to Clinical and Laboratory Standards Institute (CLSI). Most of 593 gram negative bacilli isolated were isolated from sputum (39.3 ), urine (23.1 ) and blood (9.8 ). Escherichia coli Klebsiella.spp pseudomonas aeruginosa Acinetobacter baumannii were the most common strains among the isolates. The rates of extended-spectrum -lactamases (ESBLs) in Escherichia coli and Klebsiella.spp were 53.9 and 47.9 , respectively. Carbapenems, cefepime, ceftazidime piperacillin/tazobactam, cefoperazone/sulbactam and amikacin were showed excellent activity. Bacterial distribution and the change of drug resistance should be investigated in order to guide rational drug usage in the clinic and prevent bacterial strains from being transmitted.
Introduction
Patients in the ICU have encountered an increasing emergence and spread of antimicrobial-resistant pathogens. Resistance in gram negative bacilli, including Escherichia coli, Klebsiella.spp, Acinetobacter baumannii and Pseudomonas aeruginosa, is of great concern, because a number of reports have documented mechanisms whereby these microorganisms have become resistant to all available antibacterial agents used in therapy. We investigated antimicrobial resistance and bacterial distribution of gram negative bacilli isolated from ICU in the First Bethune Hospital in 2009.
Materials And Methods

Bacterial isolates
Consecutive nonduplicate nosocomial isolates of gram negative bacilli were collected in the First Bethune Hospital in 2009. Isolates were identified at the species level using standard biochemical tests and microbiological methods.
Antimicrobial susceptibility testing
The susceptibilities of gram negative bacilli to 17 antimicrobial agents were determined by the disk diffusion method in accordance with the Clinical and Laboratory Standards Institute(CLSI) guidelines.
Detection of ESBLs production
ESBLs production was detected using the double-disk synergy (DDS) test. ESBLs presence was assayed using the following antibiotic disks (OXOID): cefotaxime (30 g), cefotaxime/clavulanic acid (30/10 g), ceftazidime (30 g), and ceftazidime/clavulanic acid (30/10 g). A 5-mm increase in a zone diameter for either antimicrobial agent tested in combination with clavulanic acid vs its zone when tested alone was ESBLs production. Klebsiella pneumoniae ATCC 700603 and Escherichia coli ATCC 25922 and ATCC 35218 strains served as quality controls.
Results
Distribution of specimen type: 593 clinical isolates of gram negative bacilli were isolated. The strains were cultured from sputum (233 isolates, 39.3 ), urine (137 isolates, 23.1 ), blood (58 isolates, 9.8 ), pus (50 isolates, 8.4%), secretion (32 isolates, 5.4%), bile (28 isolates, 4.7%), pleural fluid (25 isolates, 4.2%), abdominal fluid (20 isolates, 3.4%) and bone marrow (10 isolates, 1.7%).
Distribution of gram negative bacilli: the most common bacteria isolated were Escherichia coli (228 isolates, 38.4%), followed by Klebsiella.spp (119 isolates, 20.1%), pseudomonas aeruginosa (97 isolates, 16.4%), Acinetobacter baumannii (78 isolates, 13.2%), Stenotrophomonas maltophilia (22 isolates, 3.7%), Enterobacter.spp (20 isolates, 3.4%), Proteus.spp (15 isolates, 2.5%), Citrobacter.spp (10 isolates, 1.7%) and Serratia marcescens (4 isolates, 0.7%).
The rates of ESBLs in Escherichia coli and Klebsiella.spp were 53.9 (123/228) and 47.9 (57/119), respectively.
Resistance of pseudomonas aeruginosa, Acinetobacter baumanii, ESBLs-positive and -negative Klebsiella.spp and Escherichia coli isolates to antibiotics is shown in table 1.
Discussion
ICU patients are at increased risk of acquiring infections, most of which are associated with the use of invasive devices such as indwelling catheters, central line catheters, and mechanical ventilators [1] . Escherichia coli, Klebsiella.spp, Acinetobacter baumannii and Pseudomonas aeruginosa are now widespread nosocomial pathogens in ICU. The top three specimen types in the present study were sputum, urine and blood in ICU of the First Bethune Hospital in 2009. It is emphasized that gram negative bacilli are mainly responsible for pneumonia, urinary tract infection and septicemia in ICU of the First Bethune Hospital.
The present study showed prevalence of ESBLs-production ranging from 47.9 ~53.9 in Escherichia coli and Klebsiella.spp in ICU of the First Bethune Hospital was higher in Saudi Arabia, Iran, Taiwan, China and Canada [2] [3] [4] [5] [6] . It is associated with different geography, breakpoints, or antimicrobial susceptibility testing. Clinical laboratories need to have adequate equipment and expertise to provide detection method for ESBLs.
The resistance rates for piperacillin, ticarcillin/clavulanic acid, cefuroxime sodium, cefotaxime, ceftriaxone, ciprofloxacin, levofloxacin, gatifloxacin, trimethoprim/sulfamethoxazole were very high in ICU of the First Bethune Hospital. The resistance rates for piperacillin/tazobactam, cefoperazone/sulbactam, ceftazidime and cefepime to Escherichia coli, Klebsiella.spp and Pseudomonas were shown a relative low. The carbapenems tested in the present study showed high activity against the strains of Escherichia coli and Klebsiella.spp. However, 25.8%~38.5% Acinetobacter baumannii and Pseudomonas aeruginosa were resistant to carbapenems.
The resistance rates of ESBLs-producing Escherichia coli and Klebsiell.spp were much higher than those of non-ESBLs-producing pathogens in ICU of the First Bethune Hospital in 2009. There were differences for ESBLs-producing Escherichia coli and Klebsiell.spp among third generation cephalosporins. The resistance rates to ceftazidime were among 26.3 ~39.0 , however, those to cefotaxime and ceftriaxone were among 91.2 ~92.7
in ESBLs-producing Escherichia coli and Klebsiell.spp. The high prevalence of ESBLs-producing isolates described in this study was probably due to the large amount of third-generation cephalosporins consumed by patients in ICU. Carbapenems are effective alternative antibiotics against ESBLs-producing bacteria.
Acinetobacter baumannii and Pseudomonas aeruginosa infections have become increasingly common in ICU worldwide [7] [8] [9] . The multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa shown high resistance to almost all antibiotics in ICU of the First Bethune Hospital. It is expected that multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa is a sevious infection treatment problem in future in ICU of the First Bethune Hospital.
Prevention of antibiotic resistance by education regarding potential mechanisms, intermittent microbiologic surveillance, and use of appropriate infection-control procedures may obviate the necessity of restricting antibiotic use. Under these circumstances, use of an open formulary may avoid excessive use of certain agents.
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